M&As this week: Tecan Group, Sunovion Pharmaceuticals, Leap Therapeutics

1st September 2016 (Last Updated September 1st, 2016 18:30)

Laboratory instruments and solutions provider Tecan Group has announced its decision to acquire sample preparation solutions provider SPEware Corporation for $50m.

Laboratory instruments and solutions provider Tecan Group has announced its decision to acquire sample preparation solutions provider SPEware Corporation for $50m.

Following the acquisition, SPEware will become part of Tecan's Life Sciences Business, enabling the company to expand its dedicated solutions offerings.

Sunovion Pharmaceuticals has announced the acquisition of pharmaceutical company Cynapsus Therapeutics for $624m.

"Sunovion Pharmaceuticals has announced the acquisition of pharmaceutical company Cynapsus Therapeutics for $624m."

Sunovion develops products for the central nervous system and respiratory disorders. The acquisition of Cynapsus is part of the company's global strategy to expand its portfolio.

Immuno-oncology company Leap Therapeutics has announced its plans to acquire biopharmaceutical company Macrocure. Both companies involved in the transaction are based in the US.

Macrocure will operate as a wholly owned subsidiary of Leap Therapeutics upon completion of the transaction.

The acquisition will enable the companies to advance the development of two first-in-class, immuno-oncology monoclonal antibodies targeting aggressive cancers.